Guided Therapeutics, Inc.
Cash Flow Statement
| Line Item | FY2017 | FY2016 |
|---|---|---|
| Operating Activities | ||
| Net Income | $-10.7M | $-4.0M |
| Depreciation & Amortization | $213.0K | $1.2M |
| Depreciation | — | — |
| Amortization | — | — |
| Stock-Based Compensation | $59.0K | $95.0K |
| Net Cash from Operating Activities | $-1.1M | $-1.8M |
| Investing Activities | ||
| Capital Expenditures | — | $0 |
| Business Acquisitions | — | — |
| Net Cash from Investing Activities | — | $0 |
| Financing Activities | ||
| Dividends Paid | — | — |
| Stock Repurchases | — | — |
| Net Cash from Financing Activities | $1.1M | $1.8M |
| Net Change in Cash | $-13.0K | $-21.0K |
| Free Cash Flow | — | $-1.8M |